Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GSK · against 42 other Healthcare companies of similar size
Ranked #10 of 43 · scores higher than 76% of peers
Bars: peers in each 10-point band of the profitability score12 peers with a profitability score of 80–89, including GSK · Click a bar to see the companies
Mainly thanks to its return on assets, operating margin and return on invested capital, which are stronger than most Healthcare peers.
| Metric | GSK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 42 reported | 20.4% | 11.1% | 76% | 33% | |
| Operating marginHigher is better · 42 reported | 24.3% | 21.1% | 68% | 33% | |
| Return on assetsHigher is better · 42 reported | 9.4% | 6.7% | 63% | 33% | |
| Return on equityHigher is better · 38 reported | 33.4% | 12.5% | 86% | Context only | |
| Gross marginHigher is better · 43 reported | 73.5% | 59.1% | 81% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 11.26T JPY (≈$76.6B) | 99 | 72 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 177.5B USD | 99 | 71 | |
| 4 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 5 | 534.1B HKD (≈$68.4B) | 96 | 75 | |
| 5 | 134.5B USD | 96 | 70 | |
| 7 | 155.7B USD | 94 | 64 | |
| 8 | 56.7B USD | 93 | 79 | |
| 9 | 49.1B USD | 90 | 69 | |
| 10 | 97.5B USD | 89 | 67 | |
| 10 | 4.25T INR (≈$51.0B) | 89 | 70 | |
| 12 | 126.1B USD | 88 | 62 | |
| 12 | 100.2B USD | 88 | 57 | |
| 14 | 116.5B USD | 87 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score